Birgitte Volck - Articles and news items

Biogen Idec logo

Leading hematology journal publishes pivotal ELOCTATE™ data that demonstrated efficacy and safety of investigational long-lasting therapy for hemophilia A

Industry news / 13 November 2013 / Biogen Idec

Phase 3 study showed potential for once- or twice-weekly prophylactic dosing regimens…

Biogen Idec logo
Biogen Idec logo

New Phase 3 data reinforce long-lasting protection from bleeding for patients with Hemophilia A and B

Industry news, News / 8 February 2013 / Biogen Idec

Biogen Idec and Swedish Orphan Biovitrum released data…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...